Peter Sutherland
Family Medicine · Morristown, TNNPI 1396795480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,079 and has fallen 57.8% since, to $455 in 2023.
Across 254 payments — averaging $12.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$703
- Novo Nordisk$593
- Johnson & Johnson$338
- AbbVie$275
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$225
- Amgen$218
- plus $888 from 20 others
Across 9 payments — averaging $634.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$6K
What the payments were for
- Food & beverage$3,240100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 67 | $703 |
| Novo Nordisk | 55 | $593 |
| Johnson & Johnson | 14 | $338 |
| AbbVie(2 entities) | 23 | $275 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $225 |
| Amgen | 16 | $218 |
| Pfizer | 17 | $184 |
| Novartis | 8 | $95 |
| Astellas Pharma US Inc | 5 | $80 |
| Sanofi-aventis U.S. LLC | 4 | $64 |
| E.r. Squibb & Sons, L.L.C. | 4 | $63 |
| Lilly USA, LLC | 4 | $60 |
| AstraZeneca | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $37 |
| Radius Health, Inc. | 2 | $37 |
| Merck | 2 | $31 |
| Dexcom, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Inogen, Inc. | 1 | $18 |
| Biogen | 1 | $18 |
| Corium, LLC | 1 | $17 |
| Mylan Specialty L.p. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$104
How this compares
$3,240 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $20,183 |
| EliquisApixaban | 22 | $17,517 |
| Valsartan | 27 | $1,367 |
| Atorvastatin Calcium | 115 | $1,120 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 20 | $1,068 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $914 |
| Levothyroxine Sodium | 105 | $910 |
| Omeprazole | 77 | $754 |
| Pantoprazole Sodium | 68 | $682 |
| Pravastatin Sodium | 47 | $615 |
| Metformin Hcl | 67 | $472 |
| Amlodipine Besylate | 92 | $470 |
| Gabapentin | 66 | $452 |
| Losartan Potassium | 52 | $427 |
| Rosuvastatin Calcium | 27 | $425 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $593 | $20,18318 claims |
| PfizerEliquis | $184 | $17,51722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Morristown
- Justin GarrisonMorristown$35K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.